Morepen Laboratories Limited confirms that there were no deviations in the utilization of proceeds from its Qualified Institutional Placement (QIP) for the quarter ended December 31, 2024. The company reviewed this statement through its Audit Committee, ensuring transparency in financial practices. This consistent management of funds may reflect positively on the company’s governance and financial discipline, potentially enhancing investor confidence. Overall, this update suggests a stable operational footing, which could create a positive outlook for current and prospective shareholders.